Kölmel K, Hünecke P
Arch Dermatol Res. 1980;268(3):261-9. doi: 10.1007/BF00404287.
The influence of pharmaceutics with unknown modes of action on an ultraviolet erythema with familiar etiology offers conclusions as to the pharmaceutic's points of operation. Inversely, the influence of pharmaceutics with a known mode of action on erythemas whose pathomechanism is unknown permits insights into the erythemas' etiology. Based upon these propositions a new precise method for measuring intensities of erythema was developed. The article describes the use of this method in investigating various types of erythemas and the influence of different drugs upon them. The objective measurement of various erythemas was conducted by means of reflectometry. The term "treatment factor" is newly introduced and defined as a quotient of the reflectance of treatment and control fields. The data processing method used to evaluate the individual reflectance values is elaborated. Various possibilities for coordinating control and test fields are illustrated.
作用方式不明的药剂对病因明确的紫外线红斑的影响,可为该药剂的作用点提供结论。反之,作用方式已知的药剂对发病机制不明的红斑的影响,则有助于深入了解红斑的病因。基于这些命题,开发了一种新的精确测量红斑强度的方法。本文描述了该方法在研究各类红斑以及不同药物对其影响方面的应用。通过反射测量法对各类红斑进行客观测量。新引入了“治疗因子”这一术语,并将其定义为治疗区域与对照区域反射率的商。阐述了用于评估各个反射率值的数据处理方法。说明了协调对照区域和测试区域的各种可能性。